Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: GlobalData
Provider: Stock Traders Daily
Provider: New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Myriad Genetics Inc to acquire Crescendo Bioscience Inc

Tuesday, 4 Feb 2014 04:03pm EST 

Myriad Genetics Inc:Says it has entered into a definitive agreement to acquire Crescendo Bioscience, Inc.Says the transaction is expected to close before the end of Myriad's fiscal year 2014.Says JP Morgan Securities LLC is acting as financial advisor to Myriad Genetics and Mintz Levin Cohn Ferris Glovsky and Popeo PC is serving as legal counsel. 

Company Quote

0.08 +0.22%
11:14am EST